News
-
Announcement of Results – EP PerMed Twinning Call 2026
Six high-quality projects have been selected for funding under the EP PerMed Twinning Call 2026, an initiative designed to accelerate the implementation of personalised medicine approaches across Europe through the transfer of knowledge, expertise, and proven practices between healthcare organisations.
-
Pre-announcement – EP PerMed Joint Transnational Call (JTC) 2027
EP PerMed is launching the Joint Transnational Call 2027 ‘Cell and Gene Therapy for Personalised Medicine’ (CGT4PM2027). The call aims to fund projects focusing on the development and validation of innovative and novel cell and gene therapies for personalised medicine. The full call text is expected to be published on 4 November 2026.
-
JA PCM Invites Stakeholders to Shape a Public-Private Partnership for Personalised Cancer Medicine
The Joint Action on Personalised Cancer Medicine (JA PCM) is inviting patients, citizens and public stakeholders to two online consultations on 26 and 27 October 2026. The discussions will contribute to the development of a possible public-private partnership (PPP) for personalised cancer medicine that could continue beyond the Joint Action.
-
Commission Webinar on Pre-Commercial Procurement for Health and Cancer
The European Commission will host an information webinar on 12 October 2026 on pre-commercial procurement (PCP) in Horizon Europe. Organised by the Commission’s Health Innovation and Ecosystems Unit and the EU Cancer Mission, the session will present two 2027 funding topics: Cancer technologies, medical devices and medicines and Health adaptation to climate change.
EP PerMed JTC2027
Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
The EP PerMed Joint Transnational Call 2027 ‘Cell and Gene Therapy for Personalised Medicine’ (CGT4PM2027) aims to fund projects focusing on the development and validation of innovative and novel cell and gene therapies for personalised medicine.
EP PerMed Stakeholder Forum
Join to move personalised medicine forward!
The EP PerMed Stakeholder Forum brings together researchers, clinicians, companies, patients, regulatory stakeholders, and other key players in personalised medicine (PM) on a single platform to accelerate the translation of research findings into clinical practice and marketable applications.
Showcase your own expertise and interests in personalised medicine, either scientifically or along the value chain for implementation. Find others with exactly the knowledge you need for your next steps or be found by others, who specifically need your advice. You can reach out to potentially interesting partners directly within the platform to initiate a first contact.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.